ACE2 treatment is also one of the only therapies to reverse murine BMPR2-related PAH, the cause of most heritable PH (Johnson et al., 2012), and improves right ventricular function under stress (Johnson et al., 2011). Here, ACE2 is linked to pulmonary arterial hypertension.